세계의 바이오시뮬레이션 시장 보고서(2025년)

Biosimulation Global Market Report 2025

US $ 4,490 ￦ 6,496,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 6,490 ￦ 9,390,000

PDF (Site License)

PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,490 ￦ 12,284,000

PDF (Enterprise License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

바이오시뮬레이션 시장 규모는 향후 몇 년동안 빠르게 성장하여 2029년까지 17.8%의 연평균 성장률(CAGR)로 96억 5,000만 달러에 달할 것으로 예상됩니다. 예측 기간 동안의 성장은 희귀질환 연구에서의 바이오시뮬레이션, 약력학 모델링에 대한 집중, 임상시험의 환자 계층화, 바이오 의약품의 급격한 성장, 약물 재사용의 바이오시뮬레이션, 더 안전하고 효능이 높은 약물에 대한 수요 등에 기인합니다. 예측 기간의 주요 동향으로는 디지털 R&D 전략, 시뮬레이션 소프트웨어의 기술 발전, 바이오마커 식별을 위한 바이오시뮬레이션, 임상시험 설계 최적화, 디지털 바이오마커 및 엔드포인트, 계산생물학의 지속적인 발전 등이 있습니다.

세계 헬스케어 지출 증가는 예측 기간 동안 바이오시뮬레이션 시장을 강화할 것으로 예상됩니다. 헬스케어 지출 증가는 의약품 개발에 대한 투자 증가로 이어져 바이오시뮬레이션 솔루션의 수익을 증가시킬 것으로 예상됩니다. 바이오시뮬레이션 소프트웨어는 질병을 시뮬레이션하기 위해 의약품 개발에 점점 더 많이 활용되고 있습니다. 이 기술은 컴퓨터를 이용해 질병을 시뮬레이션함으로써 신약의 가상 임상시험을 가능하게 합니다. 예를 들어, 2024년 7월, 미국 의사협회는 2022년 미국의 의료비 지출이 4.1% 증가하여 4조 5,000억 달러(1인당 1만 3,493달러)에 달할 것이라고 보고했습니다. 따라서 의료비 지출의 급격한 증가가 바이오시뮬레이션 시장의 성장을 주도하고 있습니다.

만성질환의 유병률 증가는 향후 바이오시뮬레이션 시장의 성장을 가속할 것으로 예상됩니다. 만성질환은 장기간, 종종 평생 동안 지속되는 질병입니다. 바이오시뮬레이션은 만성질환의 복잡한 메커니즘을 이해하고, 의약품 개발 및 맞춤 치료 전략을 지원하는 데 중요한 역할을 하고 있습니다. 예를 들어, 스위스에 본부를 둔 유엔 전문기구인 세계보건기구(WHO)에 따르면, 2023년 9월 기준 전 세계 비감염성 질환(NCDs) 또는 만성질환으로 인한 사망자 수는 4,100만 명으로 전체 사망자 수의 74%를 차지합니다. 이 중 심혈관 질환으로 인한 사망자가 1,790만 명, 암으로 인한 사망자가 930만 명, 만성 호흡기 질환으로 인한 사망자가 410만 명, 당뇨병으로 인한 사망자가 200만 명에 달할 전망입니다. 따라서 만성질환의 유병률 증가가 바이오시뮬레이션 시장의 성장을 견인하고 있습니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 - 금리, 인플레이션, 지정학, 코로나재난, 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

• 세계의 바이오시뮬레이션 시장 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인, 억제요인)
• 최종 이용 산업 분석
• 세계의 바이오시뮬레이션 시장 성장률 분석
• 세계의 바이오시뮬레이션 시장 실적 : 규모와 성장, 2019-2024년
• 세계의 바이오시뮬레이션 시장 예측 : 규모와 성장, 2024-2029년, 2034년
• 세계의 바이오시뮬레이션 유효 시장(TAM)

제6장 시장 세분화

• 세계의 바이오시뮬레이션 시장 : 제품별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 소프트웨어
• 서비스
• 세계의 바이오시뮬레이션 시장 : 용도별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 의약품 개발
• Drug Discovery
• 기타 용도
• 세계의 바이오시뮬레이션 시장 : 최종사용자별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 제약 기업 및 바이오테크놀러지 기업
• 의약품 개발업무수탁(CRO)
• 규제기관
• 학술연구기관
• 기타 최종사용자
• 세계의 바이오시뮬레이션 시장 : 소프트웨어 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 약물동태(PK) 시뮬레이션 소프트웨어
• 약역학(PD) 시뮬레이션 소프트웨어
• 독성학 시뮬레이션 소프트웨어
• 질환 모델링 소프트웨어
• 통합 바이오시뮬레이션 플랫폼
• 세계의 바이오시뮬레이션 시장 : 서비스 서브 세분화 : 유형별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 컨설팅 서비스
• 모델 개발 서비스
• 데이터 분석 및 해석 서비스
• 트레이닝 및 지원 서비스
• 커스텀 시뮬레이션 서비스

제7장 지역별/국가별 분석

• 세계의 바이오시뮬레이션 시장 : 지역별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년
• 세계의 바이오시뮬레이션 시장 : 국가별, 분석과 예측, 2019-2024년, 2024-2029년, 2034년

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 개요

• 바이오시뮬레이션 시장 : 경쟁 구도
• 바이오시뮬레이션 시장 : 기업 개요
  • Certara Inc.
  • Dassault Systemes SE
  • Schrodinger Inc.
  • Simulations Plus Inc.
  • Rhenovia Pharma SAS

제31장 기타 주요 기업 및 혁신 기업

• Insilico Biotechnology AG
• Genedata AG
• Entelos Inc.
• Physiomics plc
• Rosa & Co. LLC.
• In Silico Biosciences Inc.
• INOSIM Software GmbH
• LeadInvent Technologies Limited
• Nuventra Pharma Sciences Inc.
• Archimedes Inc.
• VeriSIM Life Inc.
• Compugen Inc.
• Leadscope Inc.
• Pharmaceutical Product Development LLC
• Advanced Chemistry Development Inc.

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 시장의 최근 동향

제35장 시장 잠재력이 높은 국가, 부문, 전략

• 바이오시뮬레이션 시장(2029년) - 가장 새로운 기회를 제공하는 국가
• 바이오시뮬레이션 시장(2029년) - 가장 새로운 기회를 제공하는 부문
• 바이오시뮬레이션 시장(2029년) - 성장 전략
  • 시장 동향에 근거한 전략
  • 경쟁 전략

제36장 부록

LSH

영문 목차

영문목차

Biosimulation is a mathematical simulation process that uses computers to replicate biological processes and systems. The aim of biosimulation is a model-based prediction of the dynamics and behavior of biological systems.

The main types of products in the biosimulation market are software and services. The biosimulation software provides software for molecular modelling and simulation, pharmacokinetic/pharmacodynamic (PK/PD) modelling and simulation, toxicity prediction software, physiologically based pharmacokinetic modeling, and simulation (PBPK) modelling and simulation, trial design software, and others. It is used in drug development, drug discovery, and others and implemented in various verticals such as pharmaceutical and biotechnology companies, contract research organizations (CROs), regulatory authorities, academic research institutions, others.

The biosimulation market research report is one of a series of new reports from The Business Research Company that provides biosimulation market statistics, including biosimulation industry global market size, regional shares, competitors with a biosimulation market share, detailed biosimulation market segments, market trends and opportunities, and any further data you may need to thrive in the biosimulation industry. This biosimulation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The biosimulation market size has grown rapidly in recent years. It will grow from $4.47 billion in 2024 to $5.02 billion in 2025 at a compound annual growth rate (CAGR) of 12.2%. The growth in the historic period can be attributed to growing complexity of diseases, rise of in silico trials, drug development cost reduction, growing complexity of diseases, rising prevalence of chronic diseases.

The biosimulation market size is expected to see rapid growth in the next few years. It will grow to $9.65 billion in 2029 at a compound annual growth rate (CAGR) of 17.8%. The growth in the forecast period can be attributed to biosimulation in rare disease research, focus on pharmacodynamics modeling, patient stratification in clinical trials, rapid growth in biopharmaceuticals, biosimulation for drug repurposing, demand for safer and more efficacious drugs. Major trends in the forecast period include digital r&d strategies, technological advancements in simulation software, biosimulation for biomarker identification, optimization of clinical trial design, digital biomarkers and endpoints, continuous advancements in computational biology.

The rise in global healthcare expenditure is expected to bolster the biosimulation market during the forecast period. Increased healthcare spending is anticipated to lead to higher investments in drug development, thereby boosting the revenue generated from biosimulation solutions. Biosimulation software is increasingly being utilized in drug development to simulate diseases. This technology enables virtual clinical trials for new pharmaceutical drugs by using computers to run disease simulations. For example, in July 2024, the American Medical Association, a US-based organization, reported that U.S. healthcare spending increased by 4.1% in 2022, reaching $4.5 trillion, or $13,493 per person. Therefore, the surge in healthcare expenditure is driving the growth of the biosimulation market.

The rising prevalence of chronic diseases is expected to propel the growth of the biosimulation market going forward. Chronic diseases are medical conditions that persist over an extended period of time, often for a person's lifetime. Biosimulation plays a crucial role in understanding the complex mechanisms underlying chronic diseases, aiding in drug development and personalized treatment strategies. For instance, in September 2023, according to the World Health Organization, a Switzerland-based specialized agency of the United Nations, there were 41 million fatalities, constituting 74% of the total deaths attributed to non-communicable diseases (NCDs) or chronic conditions worldwide each year. These fatalities encompassed 17. 9 million deaths due to cardiovascular diseases, 9. 3 million deaths related to cancer, 4. 1 million deaths associated with chronic respiratory diseases, and 2.0 million deaths from diabetes. Therefore, the rising prevalence of chronic diseases is driving the growth of the biosimulation market.

Product innovation is becoming a key trend in the biosimulation market, with several companies focusing on developing new and advanced solutions. For example, in June 2023, Certara, Inc., a Pennsylvania-based company that accelerates drug development using proprietary biosimulation software, technology, and services, launched its new Phoenix Biosimulation Software. This software enhances pharmacokinetic (PK) and pharmacodynamic (PD) modeling, improving the efficiency of drug development while reducing costs. It achieves this through streamlined workflows and integrated data analysis tools, offering a more efficient approach to traditional drug discovery and development.

Major companies operating in the biosimulation market are focusing on cloud-based biosimulation to gain a competitive edge in the market. Cloud-based biosimulation software enables researchers to model and analyze complex biological processes remotely, facilitating collaboration and scalability in life sciences. For instance, in October 2023, Optibrium, a UK-based developer of software solutions for small molecule design, optimization, and data analysis, launched a cloud-based version of its drug discovery platform, StarDrop. The updated version maintains the full range of features and user engagement found in the desktop application. Additionally, it enhances accessibility and reduces the overall cost of ownership for clients. StarDrop, now cloud-based, is accessible from any internet-connected device, offering users a flexible way to utilize the software.

In September 2022, Cadence Design Systems Inc., a US-based computer software company acquired OpenEye Scientific Software for an undisclosed amount. With this acquisition Cadence Design Systems, Inc. is focusing on enhancing its capabilities in the field of computational molecular modeling and simulation, particularly within the realm of drug discovery and design. OpenEye Scientific Software is a US-based software company providing bio simulations software tools.

Major companies operating in the biosimulation market include Certara Inc., Dassault Systemes SE, Schrodinger Inc., Simulations Plus Inc., Rhenovia Pharma SAS, Insilico Biotechnology AG, Genedata AG, Entelos Inc., Physiomics plc, Rosa & Co. LLC., In Silico Biosciences Inc., INOSIM Software GmbH, LeadInvent Technologies Limited, Nuventra Pharma Sciences Inc., Archimedes Inc., VeriSIM Life Inc., Compugen Inc., Leadscope Inc., Pharmaceutical Product Development LLC, Advanced Chemistry Development Inc., Chemical Computing Group Inc., Immunetrics and PPD Inc., Instem India Private Limited, Evidera Inc., Biomodels LLC, PhysioStim SA, Lhasa Limited, SimBioSys Inc., Cadence Design Systems Inc., Allucent Inc.

North America was the largest region in the biosimulation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimulation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the biosimulation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Canada, Spain.

The biostimulation market includes revenues earned by entities by providing stimulation technology that provide simulations of biological processes and predict the behavior of biological systems to enhance the research and development (R&D) process. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Biosimulation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on biosimulation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for biosimulation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The biosimulation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product: Software; Services
• 2) By Application: Drug Development; Drug Discovery; Other Applications
• 3) By End User: Pharmaceutical And Biotechnology Companies; Contract Research Organizations (CROs); Regulatory Authorities; Academic Research Institutions; Other End Users
• Subsegments:
• 1) By Software: Pharmacokinetics (PK) Simulation Software; Pharmacodynamics (PD) Simulation Software; Toxicology Simulation Software; Disease Modeling Software; Integrated Biosimulation Platforms
• 2) By Services: Consulting Services; Model Development Services; Data Analysis And Interpretation Services; Training And Support Services; Custom Simulation Services.
• Companies Mentioned: Certara Inc.; Dassault Systemes SE; Schrodinger Inc.; Simulations Plus Inc.; Rhenovia Pharma SAS
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Biosimulation Market Characteristics

3. Biosimulation Market Trends And Strategies

4. Biosimulation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Biosimulation Growth Analysis And Strategic Analysis Framework

• 5.1. Global Biosimulation PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Biosimulation Market Growth Rate Analysis
• 5.4. Global Biosimulation Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Biosimulation Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Biosimulation Total Addressable Market (TAM)

6. Biosimulation Market Segmentation

• 6.1. Global Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software
• Services
• 6.2. Global Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Drug Development
• Drug Discovery
• Other Applications
• 6.3. Global Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmaceutical and Biotechnology Companies
• Contract Research Organizations (CROs)
• Regulatory Authorities
• Academic Research Institutions
• Other End Users
• 6.4. Global Biosimulation Market, Sub-Segmentation Of By Software, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Pharmacokinetics (PK) Simulation Software
• Pharmacodynamics (PD) Simulation Software
• Toxicology Simulation Software
• Disease Modeling Software
• Integrated Biosimulation Platforms
• 6.5. Global Biosimulation Market, Sub-Segmentation Of Services, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Consulting Services
• Model Development Services
• Data Analysis and Interpretation Services
• Training and Support Services
• Custom Simulation Services

7. Biosimulation Market Regional And Country Analysis

• 7.1. Global Biosimulation Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Biosimulation Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Biosimulation Market

• 8.1. Asia-Pacific Biosimulation Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Biosimulation Market

• 9.1. China Biosimulation Market Overview
• 9.2. China Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Biosimulation Market

• 10.1. India Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Biosimulation Market

• 11.1. Japan Biosimulation Market Overview
• 11.2. Japan Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Biosimulation Market

• 12.1. Australia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Biosimulation Market

• 13.1. Indonesia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Biosimulation Market

• 14.1. South Korea Biosimulation Market Overview
• 14.2. South Korea Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Biosimulation Market

• 15.1. Western Europe Biosimulation Market Overview
• 15.2. Western Europe Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Biosimulation Market

• 16.1. UK Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Biosimulation Market

• 17.1. Germany Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Biosimulation Market

• 18.1. France Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Biosimulation Market

• 19.1. Italy Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Biosimulation Market

• 20.1. Spain Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Biosimulation Market

• 21.1. Eastern Europe Biosimulation Market Overview
• 21.2. Eastern Europe Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Biosimulation Market

• 22.1. Russia Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Biosimulation Market

• 23.1. North America Biosimulation Market Overview
• 23.2. North America Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Biosimulation Market

• 24.1. USA Biosimulation Market Overview
• 24.2. USA Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Biosimulation Market

• 25.1. Canada Biosimulation Market Overview
• 25.2. Canada Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Biosimulation Market

• 26.1. South America Biosimulation Market Overview
• 26.2. South America Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Biosimulation Market

• 27.1. Brazil Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Biosimulation Market

• 28.1. Middle East Biosimulation Market Overview
• 28.2. Middle East Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Biosimulation Market

• 29.1. Africa Biosimulation Market Overview
• 29.2. Africa Biosimulation Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Biosimulation Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Biosimulation Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Biosimulation Market Competitive Landscape And Company Profiles

• 30.1. Biosimulation Market Competitive Landscape
• 30.2. Biosimulation Market Company Profiles
  • 30.2.1. Certara Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Dassault Systemes SE Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Schrodinger Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Simulations Plus Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Rhenovia Pharma SAS Overview, Products and Services, Strategy and Financial Analysis

31. Biosimulation Market Other Major And Innovative Companies

• 31.1. Insilico Biotechnology AG
• 31.2. Genedata AG
• 31.3. Entelos Inc.
• 31.4. Physiomics plc
• 31.5. Rosa & Co. LLC.
• 31.6. In Silico Biosciences Inc.
• 31.7. INOSIM Software GmbH
• 31.8. LeadInvent Technologies Limited
• 31.9. Nuventra Pharma Sciences Inc.
• 31.10. Archimedes Inc.
• 31.11. VeriSIM Life Inc.
• 31.12. Compugen Inc.
• 31.13. Leadscope Inc.
• 31.14. Pharmaceutical Product Development LLC
• 31.15. Advanced Chemistry Development Inc.

32. Global Biosimulation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Biosimulation Market

34. Recent Developments In The Biosimulation Market

35. Biosimulation Market High Potential Countries, Segments and Strategies

• 35.1 Biosimulation Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Biosimulation Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Biosimulation Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer

관련자료